Rhode Island 2026 Regular Session

Rhode Island Senate Bill S3059

Introduced

3/12/26

Refer

3/12/26

Caption

Imposes certain duties, transparency, and accountability from pharmacy benefits managers and pharmacy benefits management services.

Impact

The implications of S3059 are significant for various stakeholders, including insurers, pharmacies, and consumers. By enforcing stricter regulations on PBMs, the bill aims to create a more equitable system where pharmacies can freely communicate pricing and service information to consumers. It also seeks to protect pharmacies from potentially exploitative practices by PBMs, such as prohibiting them from disclosing pertinent cost information. Furthermore, the introduction of an appeals process for pricing disputes aims to ensure that pharmacies can contest and resolve pricing discrepancies in a fair manner.

Summary

Bill S3059 is a legislative proposal aimed at enhancing transparency and accountability among pharmacy benefit managers (PBMs) within Rhode Island's healthcare system. It amends existing laws related to pharmacy operations and the management of prescription drug benefits. The bill establishes clear definitions and duties for PBMs, ensuring they operate with the same responsibilities as insurers when interacting with covered individuals. The legislation is framed as a response to growing concerns regarding the practices of PBMs that have impacts on both the cost and accessibility of prescription medications for patients.

Contention

Notably, the bill has sparked discussions concerning its potential impact on the competitive landscape of healthcare in Rhode Island. Supporters argue that increased transparency will lead to better healthcare outcomes and lower costs for consumers. However, opponents raise concerns that the bill could lead to unintended consequences, such as increased administrative burdens on PBMs and potential changes in how they negotiate with pharmacies. This debate reflects broader tensions in the healthcare sector regarding regulation and the role of intermediaries in the prescription drug supply chain.

Companion Bills

No companion bills found.

Previously Filed As

RI S0221

Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.

RI H5429

Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.

RI S0222

Requires pharmacy benefit managers to reimburse pharmacist no less than national drug acquisition costs plus fee.

RI H5254

Requires pharmacy benefit managers to reimburse pharmacist no less than national drug acquisition costs plus fee.

RI S0117

Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).

RI H5463

Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).

RI S0165

Prohibits pharmacy benefit managers from conducting or participate in spread pricing within the state.

RI S0897

Requires health insurance providers to provide insurance coverage for pharmacists’ services.

RI H5627

Requires health insurance providers to provide insurance coverage for pharmacists’ services.

RI S0114

Prohibits any health insurer, pharmacy benefit manager, manufacturer or other third-party payor from discriminating against any 340B entity participating in a drug discount program.

Similar Bills

HI HB2225

Relating To Health.

IA SF383

A bill for an act relating to pharmacy benefits managers, pharmacies, prescription drugs, and pharmacy services administrative organizations, and including applicability provisions. (Formerly SSB 1074.) Effective date: 07/01/2025. Applicability date: 07/01/2025.